Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes

Table 1

Differences between the remission group and the nonremission group at the baseline.

	Remission group	Nonremission group	or value	value
Number	127	117	—	—
Gender (F/M)	35/92	51/66	2.613	0.011
Age (years)			-2.096	0.037
Smoking habit	25.20%	20.51%	0.867	0.386
BMI (kg/m^2)			2.007	0.046
HbA1c (%); (mmol/mol)			0.085	0.932
FPG (mmol/L)			-1.927	0.055
PPG (mmol/L)			1.503	0.134
Triglyceride (mmol/L)			0.179	0.858
Cholesterol (mmol/L)			-1.371	0.172
HDL-C (mmol/L)			-2.147	0.033
LDL-C (mmol/L)			-0.602	0.548
hsCRP (mg/L)	1.70 (2.59)	1.33 (2.17)	0.982	0.326
AIR (pmol/L·10 min)	-125.71 (263.04)	-99.36 (230.29)	0.541	0.589
HOMA-B	24.47 (31.99)	23.85 (24.02)	1.206	0.228
HOMA-IR	4.20 (4.30)	4.88 (4.95)	0.893	0.373

means . BMI: body mass index; HbA1c: glycated hemoglobin; FPG: fasting plasma glucose; PPG: postprandial plasma glucose; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; hsCRP: high-sensitivity C-reactive protein; AIR: acute insulin response; HOMA-B: homeostasis model assessment of β-cell function; HOMA-IR: homeostasis model assessment of insulin resistance; AIR: acute insulin response.